AmerisourceBergen First Quarter Earnings Sneak Peek

  Google+ | + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

S&P 500 (NYSE:SPY) component AmerisourceBergen (NYSE:ABC) will unveil its latest earnings tomorrow, Thursday, January 24, 2013. AmerisourceBergen is a pharmaceutical services company providing drug distribution and related healthcare services to pharmacy, physician, and manufacturer customers based in North America.

AmerisourceBergen Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average analyst estimate is for profit of 67 cents per share, a rise of 8.1% from the company’s actual earnings for the year-ago quarter. During the past three months, the average estimate has moved down from 69 cents. Between one and three months ago, the average estimate moved down. It also has dropped from 68 cents during the last month. Analysts are projecting profit to rise by 10.2% compared to last year’s $3.12.

Past Earnings Performance: The company is looking to top estimates for the third straight quarter. Last quarter, it reported net income of 69 cents per share against a mean estimate of profit of 68 cents, and the quarter before, the company exceeded forecasts by 3 cents with net income of 72 cents versus a mean estimate of profit of 69 cents.

Start 2013 better than ever by saving time and making money with your Limited Time Offer for our highly-acclaimed Stock Picker Newsletter. Click here for our fresh Feature Stock Pick now!

A Look Back: In the fourth quarter of the last fiscal year, profit rose 11% to $163.5 million (67 cents a share) from $147.3 million (54 cents a share) the year earlier, exceeding analyst expectations. Revenue fell 5.5% to $19.29 billion from $20.41 billion.

Wall St. Revenue Expectations: On average, analysts predict $21.69 billion in revenue this quarter, a rise of 6.5% from the year-ago quarter. Analysts are forecasting total revenue of $85.66 billion for the year, a rise of 7.8% from last year’s revenue of $79.49 billion.

Analyst Ratings: With seven analysts rating the stock a buy, none rating it a sell and three rating the stock a hold, there are indications of a bullish stance by analysts.

Here’s how AmerisourceBergen traded following its last earnings report 3 months ago and leading up to its upcoming earnings report this week:

abc

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business